Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”PPTA Europe’s visits with members and stakeholders this past year were a powerful reminder of why our work matters.
Seeing operations up close, meeting teams, walking through facilities and donation centres, and hearing real-world experiences, grounds our policy and advocacy efforts in the realities you navigate every day.
These moments of connection bring clarity to our mission and reinforce the importance of working together.
The insights gained during these visits strengthened connections and sparked new ideas for how we can collectively advance our shared goals.
Building on this momentum is a priority for 2026.
If you are interested in hosting a visit, send me a note.
These in-person exchanges deepen understanding, amplify collaboration, and help ensure our work reflects the needs and experiences of our members.
Let’s make 2026 a year of stronger connections and meaningful progress across our community.
Connected, we are stronger!”
Stay updated with Hemostasis Today.
-
May 30, 2026, 10:36Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products